4D Molecular Therapeutics, Inc. 4 filing

Filed 2025-10-20 · Report date 2025-10-16 · 2025

View Original SEC Filing

Filing metadata

Accession number: 0001193125-25-243946
Form type: 4
CIK: 0001650648
Primary document: https://www.sec.gov/Archives/edgar/data/1650648/000119312525243946/xslF345X05/ownership.xml

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for 4D Molecular Therapeutics, Inc..

Reported financial metrics

Metric	Current	Prior	Change